News
May 5, 2020

Challenges and opportunities for using AI to help people with disabilities

Videos from conference sponsored by Regenstrief, Harvard and Stanford now available online

Regenstrief Institute, Harvard University and Stanford School of Medicine hosted an online conference exploring the opportunities for leveraging artificial intelligence to improve the lives of people with disabilities and dependencies, and the entire discussion is now available for free online.

AI has potential for both positive and negative impacts on those with disabilities. Legal scholars, ethicists, AI developers, clinicians and people living with disabilities and dependencies discussed best practices and guidelines for stakeholders, articulating clear criteria for developers and medical providers who want to use AI technology to improve lives.

Regenstrief Vice President for Research Development Eneida Mendonca, M.D., PhD, helped to organize this conference. Dr. Mendonca also is a professor at Indiana University School of Medicine.

Regenstrief Researcher Noll Campbell, PharmD, participated in the conference’s panel on AI and disability. Dr. Campbell, also an assistant professor of pharmacy practice at Purdue University College of Pharmacy, is a geriatric pharmacotherapy expert. He spoke about how data used to create and train AI models may actually not help populations with certain disabilities, such as dementia, and in fact may actually cause unintended consequences.

The webinar was sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School; the Harvard Law School Project on Disability (HPOD); the Edmond J. Safra Center for Ethics at Harvard University; the Regenstrief Institute; and the Presence at the Stanford University School of Medicine. Support provided by the Oswald DeN. Cammann Fund at Harvard University.

Watch the entire conference here.

  • Harvard AI Conference

Related News

Rachel Patzer, PhD

Supply, demand, and a growing US kidney transplant waiting list

Published in JAMA Network Open. Here is a link to the article.  Regenstrief Institute author: Rachel Patzer, PhD, MPH 

Jiang Bian, PhD

Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy

Published in Journal of the American College of Cardiology (JACC) CardioOncology. Here is a link to the article.  Regenstrief

Shaun Grannis, M.D., M.S.

Study reveals gaps in flu treatment for high-risk adults

INDIANAPOLIS – A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent

Michael Weiner, MD, MPH

Regenstrief Institute researcher departs after more than two decades of service 

After more than two decades of impactful work in Indiana, Michael Weiner, M.D., MPH, is departing Regenstrief Institute, Indiana